BioXcel Therapeutics Inc.

04/24/2024 | Press release | Distributed by Public on 04/24/2024 08:34

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal[...]